8,978 Results

No clear evidence that nicotine “preloading” helps smokers to quit

 Added 17 hours ago

No clear evidence that nicotine “preloading” helps smokers to quit

Any beneficial effect may have been masked by reduction in use of smoking cessation drug

Oral semaglutide shows statistically significantly greater reductions in HbA1c and weight compared to Victoza and sitagliptin in the PIONEER 4 and 7 trials.- Novo Nordisk.

 Added 17 hours ago

Novo Nordisk announced the successful completion and headline results of the phase IIIa trials PIONEER 4 comparing oral semaglutide as...

NICE issues positive guidance on use of MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor.- Insightec.

 Added 17 hours ago

Insightec announced that The National Institute for Health and Care Excellence (NICE) issued a positive NICE guidance for unilateral MRI-guided...

FDA approves expanded label for Cinryze to treat children with hereditary angioedema .- Shire plc.

 Added 17 hours ago

Shire plc announced that the FDA has approved a label expansion for Cinryze (C1 esterase inhibitor [human]), making it available...

Idorsia initiates PRECISION Phase III trial of aprocitentan for resistant hypertension management .

 Added 17 hours ago

Idorsia announced that the first patient has been enrolled into PRECISION, a Phase III study to investigate the efficacy and...

Stanford scientists discover biomarker for flu susceptibility

 Added 1 day ago

Stanford scientists discover biomarker for flu susceptibility

Scientists at Stanford are believed to be the first to have discovered a biomarker that can predict who will be most susceptible to influenza.

Top-Line Results reported from Cingal 16-02 Clinical Trial in Knee Osteoarthritis.- Anika Therapeutics.

 Added 1 day ago

Anika Therapeutics, Inc.announced results from its Cingal 16-02 clinical trial, an active-comparator Phase III study being conducted to support U.S....

Evotec AG to integrate Sanofi's infectious diseases unit into its organisation.

 Added 2 days ago

Evotec AG announced having signed a transaction agreement with Sanofi to integrate Sanofi’s infectious disease unit into its organisation. Pursuant to...

FDA grants 510(k) approval to Omnipod DASH Insulin Management System.- Insulet Corporation.

 Added 1 day ago

Insulet Corporation, the leader in tubeless insulin pump technology with its Omnipod Insulin Management System (Omnipod System), announced FDA 510(k)...

ALXN 1210 filed with rare disease priority at FDA for paroxysmal nocturnal hemoglobinuria.- Alexion Pharma.

 Added 2 days ago

Alexion Pharmaceuticals announced the submission of a Biologics License Application (BLA) to the FDA for approval of ALXN 1210, the...

Load more